MEDI-538
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI-538, covering 2008-09-05 to 2008-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]